Integral Health Asset Management, LLC
Filing Date
Global Rank
#1,170
/ 8,603
▲ 54
· as of Mar 2026
Top Industry
Biotechnology
69.7%
3Y Alpha vs SPY
-1.3%
Period ended 3 months ago
Filed May 15, 2026 · 55d
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+69.9%
SPY
+76.0%
Annualised alpha
-1.4%
Max drawdown
−26.3%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
86 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
12.8%
+1.8 pts
Top 5
38.9%
+8.3 pts
Top 10
51.8%
+7.9 pts
HHI
470
Diversified+151
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $2,090,923,180 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| RVMD | Revolution Medicines, Inc. | +1,550,000 | 2,750,000 | $267,437,500 | |
| LFST | LifeStance Health Group, Inc. | +1,300,000 | 4,300,000 | $27,391,000 | |
| ROIV | Roivant Sciences Ltd. | +1,150,000 | 2,000,000 | $55,400,000 | |
| CYTK | Cytokinetics Inc | +700,000 | 2,600,000 | $171,366,000 | |
| BTSG | BrightSpring Health Services, Inc. | +500,000 | 1,250,000 | $53,262,500 | |
| NRIX | Nurix Therapeutics, Inc. | +400,000 | 700,000 | $10,850,000 | |
| ALHC | Alignment Healthcare, Inc. | +375,000 | 2,575,000 | $45,371,500 | |
| BSX | Boston Scientific Corp | +325,000 | 550,000 | $34,512,500 | |
| ELAN | Elanco Animal Health Inc | +300,000 | 550,000 | $13,161,500 | |
| RGNX | REGENXBIO Inc. | +300,000 | 1,500,000 | $12,570,000 | |
| MLYS | Mineralys Therapeutics, Inc. | +250,000 | 1,250,000 | $33,862,500 | |
| TNGX | Tango Therapeutics, Inc. | +250,000 | 450,000 | $9,414,000 | |
| INSM | INSMED Inc | +250,000 | 1,500,000 | $245,280,000 | |
| SANA | Sana Biotechnology, Inc. | +200,000 | 3,200,000 | $9,216,000 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | +200,000 | 300,000 | $18,810,000 | |
| ORIC | Oric Pharmaceuticals, Inc. | +200,000 | 1,400,000 | $17,738,000 | |
| SRRK | Scholar Rock Holding Corp | +200,000 | 500,000 | $24,580,000 | |
| MRK | Merck & Co., Inc. | +175,000 | 425,000 | $51,123,250 | |
| VKTX | Viking Therapeutics, Inc. | +150,000 | 250,000 | $8,135,000 | |
| SNDX | Syndax Pharmaceuticals Inc | +150,000 | 350,000 | $8,176,000 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | +125,000 | 600,000 | $52,182,000 | |
| ANRO | Alto Neuroscience, Inc. | +125,000 | 500,000 | $11,240,000 | |
| FMS | Fresenius Medical Care AG | +125,000 | 775,000 | $17,484,000 | |
| EWTX | Edgewise Therapeutics, Inc. | +100,000 | 1,600,000 | $50,400,000 | |
| EVMN | Evommune, Inc. | +100,000 | 225,000 | $5,172,750 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
17 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| TARA | Protara Therapeutics, Inc. | −500,000 | 1,750,000 | $9,117,500 | |
| BHVN | Biohaven Ltd. | −500,000 | 1,000,000 | $8,460,000 | |
| IKT | Inhibikase Therapeutics, Inc. | −400,000 | 1,350,000 | $2,268,000 | |
| CVS | CVS HEALTH Corp | −350,000 | 150,000 | $10,773,000 | |
| DXCM | Dexcom Inc | −325,000 | 175,000 | $10,990,000 | |
| BEAM | Beam Therapeutics Inc. | −250,000 | 300,000 | $7,149,000 | |
| VERA | Vera Therapeutics, Inc. | −200,000 | 1,600,000 | $64,368,000 | |
| COO | Cooper Companies, Inc. | −175,000 | 150,000 | $10,725,000 | |
| EW | Edwards Lifesciences Corp | −155,000 | 170,000 | $13,613,600 | |
| GKOS | GLAUKOS Corp | −150,000 | 175,000 | $18,840,500 | |
| NVST | Envista Holdings Corp | −150,000 | 350,000 | $8,879,500 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | −125,000 | 150,000 | $12,588,000 | |
| ISRG | Intuitive Surgical Inc | −75,000 | 35,000 | $16,134,650 | |
| BIIB | Biogen Inc. | −40,000 | 60,000 | $10,999,800 | |
| REGN | Regeneron Pharmaceuticals, Inc. | −20,000 | 85,000 | $65,674,400 | |
| DGX | Quest Diagnostics Inc | −15,000 | 60,000 | $11,758,800 | |
| LLY | ELI LILLY & Co | −5,000 | 15,000 | $13,796,550 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AZN | Astrazeneca PLC | 250,000 | $49,305,000 | |
| BBIO | BridgeBio Pharma, Inc. | 275,000 | $20,421,500 | |
| VRTX | Vertex Pharmaceuticals Inc / Ma | 40,000 | $17,861,600 | |
| ALMS | Alumis Inc. | 800,000 | $17,624,000 | |
| GILD | Gilead Sciences, Inc. | 100,000 | $13,937,000 | |
| COGT | Cogent Biosciences, Inc. | 350,000 | $13,471,500 | |
| MDGL | Madrigal Pharmaceuticals, Inc. | 25,000 | $13,086,750 | |
| XENE | Xenon Pharmaceuticals Inc. | 200,000 | $11,630,000 | |
| ERAS | Erasca, Inc. | 700,000 | $11,326,000 | |
| IRON | Disc Medicine, Inc. | 170,000 | $10,869,800 | |
| TMO | Thermo Fisher Scientific Inc. | 20,000 | $9,830,600 | |
| LIVN | LivaNova PLC | 150,000 | $9,534,000 | |
| IONS | Ionis Pharmaceuticals Inc | 125,000 | $9,386,250 | |
| DFTX | Definium Therapeutics, Inc. | 400,000 | $7,560,000 | |
| CAPR | Capricor Therapeutics, Inc. | 200,000 | $6,080,000 | |
| IQV | Iqvia Holdings Inc. | 35,000 | $5,968,900 | |
| AXSM | Axsome Therapeutics, Inc. | 35,000 | $5,915,700 | |
| PTGX | Protagonist Therapeutics, Inc | 50,000 | $5,270,000 | |
| ACHC | Acadia Healthcare Company, Inc. | 200,000 | $4,678,000 | |
| ZBH | Zimmer Biomet Holdings, Inc. | 50,000 | $4,521,000 | |
| FBRX | Forte Biosciences, Inc. | 150,000 | $3,885,000 | |
| SVRA | Savara Inc | 600,000 | $3,276,000 | |
| RLMD | Relmada Therapeutics, Inc. | 450,000 | $3,132,000 | |
| IMCR | Immunocore Holdings plc | 100,000 | $3,015,000 | |
| OLMA | Olema Pharmaceuticals, Inc. | 150,000 | $2,236,500 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
24 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| MDT | Medtronic plc | 675,000 | $64,840,500 | |
| TEVA | Teva Pharmaceutical Industries Ltd | 1,000,000 | $31,210,000 | |
| PEN | Penumbra Inc | 100,000 | $31,091,000 | |
| TFX | Teleflex Inc | 250,000 | $30,510,000 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 60,000 | $23,859,000 | |
| IRTC | iRhythm Holdings, Inc. | 130,000 | $23,067,200 | |
| UPB | Upstream Bio, Inc. | 750,000 | $20,362,500 | |
| THC | Tenet Healthcare Corp | 100,000 | $19,872,000 | |
| DOCS | Doximity, Inc. | 400,000 | $17,712,000 | |
| TERN | Terns Pharmaceuticals, Inc. | 425,000 | $17,170,000 | |
| UNH | Unitedhealth Group Inc | 50,000 | $16,505,500 | |
| RDNT | RadNet, Inc. | 200,000 | $14,270,000 | |
| ACLX | Arcellx, Inc. | 200,000 | $13,040,000 | |
| EHC | Encompass Health Corp | 100,000 | $10,614,000 | |
| CRL | Charles River Laboratories International, Inc. | 45,000 | $8,976,600 | |
| INSP | Inspire Medical Systems, Inc. | 75,000 | $6,917,250 | |
| BRKR | Bruker Corp | 125,000 | $5,888,750 | |
| APLS | Apellis Pharmaceuticals, Inc. | 200,000 | $5,024,000 | |
| EYPT | EyePoint, Inc. | 200,000 | $3,654,000 | |
| GPCR | Structure Therapeutics Inc. | 50,000 | $3,477,500 | |
| SGHT | Sight Sciences, Inc. | 425,000 | $3,370,250 | |
| GOSS | Gossamer Bio, Inc. | 1,000,000 | $3,100,000 | |
| OSCR | Oscar Health, Inc. | 200,000 | $2,874,000 | |
| BCRX | Biocryst Pharmaceuticals Inc | 200,000 | $1,560,000 | |
| No positions match the current search. | ||||
86 positions ·
$2,090,923,180 total
· as of Mar 31, 2026
Showing 1–50
of 86 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 2,750,000 | $267,437,500 | 12.79% | |
| INSM |
INSMED Inc
Healthcare
|
Added | 1,500,000 | $245,280,000 | 11.73% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Added | 2,600,000 | $171,366,000 | 8.20% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
Reduced | 85,000 | $65,674,400 | 3.14% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Reduced | 1,600,000 | $64,368,000 | 3.08% | |
| CAH |
Cardinal Health Inc
Healthcare
|
Added | 270,000 | $57,053,700 | 2.73% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Added | 2,000,000 | $55,400,000 | 2.65% | |
| BTSG |
BrightSpring Health Services, Inc.
Healthcare
|
Added | 1,250,000 | $53,262,500 | 2.55% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Added | 600,000 | $52,182,000 | 2.50% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
Added | 425,000 | $51,123,250 | 2.45% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Added | 1,600,000 | $50,400,000 | 2.41% | |
| AZN |
Astrazeneca PLC
Healthcare
|
NEW | 250,000 | $49,305,000 | 2.36% | |
| ALHC |
Alignment Healthcare, Inc.
Healthcare
|
Added | 2,575,000 | $45,371,500 | 2.17% | |
| NVS |
Novartis AG
Healthcare
|
Held | 250,000 | $38,187,500 | 1.83% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Added | 550,000 | $34,512,500 | 1.65% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Added | 1,250,000 | $33,862,500 | 1.62% | |
| LFST |
LifeStance Health Group, Inc.
Healthcare
|
Added | 4,300,000 | $27,391,000 | 1.31% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Added | 115,000 | $26,303,950 | 1.26% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Added | 500,000 | $24,580,000 | 1.18% | |
| ELV |
Elevance Health, Inc.
Healthcare
|
Added | 75,000 | $21,956,250 | 1.05% | |
| CNC |
Centene Corp
Healthcare
|
Held | 650,000 | $21,281,000 | 1.02% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
NEW | 275,000 | $20,421,500 | 0.98% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Held | 150,000 | $19,761,000 | 0.95% | |
| GKOS |
GLAUKOS Corp
Healthcare
|
Reduced | 175,000 | $18,840,500 | 0.90% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
Added | 300,000 | $18,810,000 | 0.90% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
NEW | 40,000 | $17,861,600 | 0.85% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Added | 1,400,000 | $17,738,000 | 0.85% | |
| ALMS |
Alumis Inc.
Healthcare
|
NEW | 800,000 | $17,624,000 | 0.84% | |
| FMS |
Fresenius Medical Care AG
Healthcare
|
Added | 775,000 | $17,484,000 | 0.84% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Reduced | 35,000 | $16,134,650 | 0.77% | |
| QURE |
uniQure N.V.
Healthcare
|
Held | 900,000 | $14,715,000 | 0.70% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Held | 200,000 | $14,030,000 | 0.67% | |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
NEW | 100,000 | $13,937,000 | 0.67% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Reduced | 15,000 | $13,796,550 | 0.66% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
Reduced | 170,000 | $13,613,600 | 0.65% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
NEW | 350,000 | $13,471,500 | 0.64% | |
| ELAN |
Elanco Animal Health Inc
Healthcare
|
Added | 550,000 | $13,161,500 | 0.63% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
NEW | 25,000 | $13,086,750 | 0.63% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Held | 40,000 | $12,887,600 | 0.62% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Reduced | 150,000 | $12,588,000 | 0.60% | |
| RGNX |
REGENXBIO Inc.
Healthcare
|
Added | 1,500,000 | $12,570,000 | 0.60% | |
| DGX |
Quest Diagnostics Inc
Healthcare
|
Reduced | 60,000 | $11,758,800 | 0.56% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
NEW | 200,000 | $11,630,000 | 0.56% | |
| ERAS |
Erasca, Inc.
Healthcare
|
NEW | 700,000 | $11,326,000 | 0.54% | |
| ANRO |
Alto Neuroscience, Inc.
Healthcare
|
Added | 500,000 | $11,240,000 | 0.54% | |
| BIIB |
Biogen Inc.
Healthcare
|
Reduced | 60,000 | $10,999,800 | 0.53% | |
| DXCM |
Dexcom Inc
Healthcare
|
Reduced | 175,000 | $10,990,000 | 0.53% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
Held | 325,000 | $10,881,000 | 0.52% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
NEW | 170,000 | $10,869,800 | 0.52% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Added | 700,000 | $10,850,000 | 0.52% |